Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold re...